Hot Investor Mandate: USA Family Office Invests in Global Therapeutics, Devices, and Diagnostics, with Strong Interest in Discovery to Pre-Clinical Technologies

18 Jul

A family office based in the USA invests in primarily early-stage (seed, Series A, Series B) companies with truly innovative technologies. The firm will generally lead investments and invests globally with no geographic restrictions.

The firm is agnostic across life science sectors, including therapeutics, devices and tools, but will not consider healthcare IT or digital health technologies. The firm focuses on discovery, early stage preclinical and clinical-stage opportunities, though may be open to commercial-stage or adjacent discovery/ development technologies.

The firm is seeking companies with founders who have a clear vision and desire to build a durable business.

If you are interested in more information about this investor and other investors tracked by LSN, please email mandates@lifesciencenation.com.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: